Role of lamellar body count for the prediction of neonatal respiratory distress syndrome in non-diabetic pregnant women

被引:15
作者
Ghidini A. [1 ]
Poggi S.H. [1 ]
Spong C.Y. [1 ]
Goodwin K.M. [1 ]
Vink J. [2 ]
Pezzullo J.C. [3 ]
机构
[1] Dept. of Obstetrics and Gynecology, Georgetown University Hospital, Washington, DC 20007, 3PHC 3800 Reservoir Road, N.W.
[2] Univ. of Virginia Medical School, Charlottesville, VA
[3] Dept. of Pharmacol. and Biostatist., Georgetown University Hospital, Washington, DC
关键词
Fetal lung maturity; Lamellar body count; Respiratory distress syndrome;
D O I
10.1007/s00404-004-0653-7
中图分类号
学科分类号
摘要
Objective: Lamellar body count is a new and fast technique to establish the presence of fetal lung maturity. We have assessed the predictive ability of lamellar body count for neonatal respiratory distress syndrome (RDS) in a non-diabetic population. Study design: We accessed a cohort of amniocenteses in non-diabetic women from 1998 to 2002 (n=102). Neonatal RDS was defined as need for surfactant, intubation, or continuous positive airway pressure (CPAP) in the setting of chest X-ray findings consistent with RDS. The predictive ability of lamellar body count was compared with those of lecithin/sphingomyelin (L/S) ratio and presence of phosphatidylglycerol (PG) using logistic regression analysis. The optimal threshold value of lamellar body count for prediction of neonatal RDS was established with receiver operating characteristic (ROC) curve analysis. Results: Lamellar body count ROC curve analysis identified a lamellar body count >37,000 μl-1 as optimal diagnostic threshold for diagnosis of lung maturity, having a negative predictive value of 98%. Lamellar body count and PG, but not L/S ratio, added significantly to the prediction of RDS. Conclusions: Lamellar body count is a reliable predictor of fetal lung maturity in non-diabetic women and it can replace the L/S ratio. © Springer-Verlag 2004.
引用
收藏
页码:325 / 328
页数:3
相关论文
共 12 条
[1]  
Gluck L., Kulovich M., Borer R.C., Brenner P.H., Anderson G.G., Spellacy W.N., Diagnosis of respiratory distress by amniocentesis, Am J Obstet Gynecol, 109, pp. 440-445, (1971)
[2]  
Hallman M., Kulovich M., Kirkpatrick E., Sugarman R., Gluck L., Phophatidylinositol and phosphatidylglycerol in amniotic fluid: Indices of lung maturity, Am J Obstet Gynecol, 125, pp. 613-617, (1976)
[3]  
Neerhof M.G., Dohnal J.C., Ashwood E.R., Lee I.S., Anceschi M.M., Lamellar body counts: A consensus on protocol, Obstet Gynecol, 97, pp. 318-320, (2001)
[4]  
Greenspoon J.S., Rosen D.J.D., Roll K., Dubin S.B., Evaluation of lamellar body number density as the initial assessment in a fetal lung maturity test cascade, J Reprod Med, 40, pp. 260-266, (1995)
[5]  
Ashwood E.R., Palmer S.E., Taylor J.S., Pingree S.S., Lamellar body counts for rapid fetal lung maturity testing, Obstet Gynecol, 81, pp. 619-624, (1993)
[6]  
Dubin S.B., Characterization of amniotic fluid lamellar bodies by resistive-pulse counting: Relationship to measures of fetal lung maturity, Clin Chem, 35, pp. 612-616, (1989)
[7]  
Neerhof M.G., Haney E.I., Silver R.K., Ashwood E.R., Lee I., Piazze J.J., Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity, Obstet Gynecol, 97, pp. 305-309, (2001)
[8]  
Ghidini A., Spong C.Y., Goodwin K., Pezzullo J.C., Optimal thresholds of lecithin/sphingomyelin ratio and lamellar body count for the prediction of the presence of phosphatidylglycerol in diabetic women, J Matern Fetal Neonatal Med, 12, pp. 95-98, (2002)
[9]  
Lewis P.S., Lauria M.R., Dzieczkowksi J., Utter G.O., Dombrowski M.P., Amniotic fluid lamellar body count: Cost-effective screening for fetal lung maturity, Obstet Gynecol, 93, pp. 387-391, (1999)
[10]  
Dalence C.R., Bowie L.J., Dohnal J.C., Farrell E.E., Neerhof M.G., Amniotic fluid lamellar body count: A rapid and reliable fetal lung maturity test, Obstet Gynecol, 86, pp. 235-239, (1995)